Rep. DeLauro investigates recent device approvals
This article was originally published in The Gray Sheet
Executive Summary
Rep. Rosa DeLauro, D-Conn., requests information from FDA on all devices, drugs and biologic products approved or cleared during the final days of the Bush administration - between November 2008 and January 2009. "I long have been concerned about the influence of industry and political interests in the approval process," DeLauro wrote in a Feb. 12 letter to acting FDA Commissioner Frank Torti. "I fear that this influence has permeated the culture of the agency and has resulted in the approval of a number of products that later were proven to be unsafe and/or ineffective." DeLauro asks for a response by Feb. 26